Asia'a largest vaccine event
Dr Rodney Hoff | Executive Director
Regional Emerging Diseases Intervention (REDI) Center
|
Dr. Rod Hoff is the Executive Director of the REDI Centre in Singapore, which is jointly supported by the Ministry of Health of Singapore and the Department of Health and Human Services of the United States. The Centre has a mission to enhance the capability and capacity to monitor, detect and respond to emerging disease threats in the Asian Pacific region. Currently REDI Centre is conducting regional projects on avian influenza and pandemic influenza preparedness with a major focus on training referral hospitals for case management and infection control and a pilot project for control of avian influenza in Tangerang, Indonesia. REDI Center is also moving into projects on hand foot and mouth disease, Dengue and Chikungunya, while monitoring the expansion of HIV/AIDS in several countries in the region. Before coming to REDI Centre, Dr. Hoff worked on national and international aspects of HIV/AIDS at the National Institutes of Health of United States. In the mid-1980s he developed a novel technique for determining the seroprevalence of HIV in childbearing women, which produced the first national estimates of HIV infection in the United States. During his career at the NIH, he organized and directed the HIVNET and HPTN clinical trial networks for evaluating HIV vaccines and other preventive interventions for HIV/AIDS. For the past 5 years, he has led the Comprehensive International Program of Research on AIDS (CIPRA), which provides longterm research and infrastructure support to research organizations in developing countries to enhance their capabilities and capacity to conduct HIV/AIDS research relevant to their populations. In addition to AIDS, Dr. Hoff has conducted research on Chagas' disease, schistosomiasis, Leishmaniasis, toxoplasmosis, malaria and other emerging and re-emerging infectious diseases. |
Share this |
Appearances at this years' conference:
